Email this article 
Adiponectin: Role in Physiology and Pathophysiology
Abstract
Keywords
Full Text:
PDFReferences
Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF.
A novel serum protein similar to C1q, produced exclusively in
adipocytes. J Biol Chem 1995;270:26746‑9.
Hu E, Liang P, Spiegelman BM. AdipoQ is a novel
adipose‑specific gene dysregulated in obesity. J Biol Chem
;271:10697‑703.
Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y,
Matsubara K. cDNA cloning and expression of a novel adipose
specific collagen‑like factor, apM1 (AdiPose Most abundant Gene
transcript 1). Biochem Biophys Res Commun 1996;221:286‑9.
Nakano Y, Tobe T, Choi‑Miura NH, Mazda T, Tomita M. Isolation
and characterization of GBP28, a novel gelatin‑binding protein
purified from human plasma. J Biochem 1996;120:803‑12.
Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM.
Induction of adiponectin in skeletal muscle by inflammatory
cytokines: In vivo and in vitro studies. Endocrinology
;145:5589‑97.
Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J,
et al. Adiponectin is synthesized and secreted by human and
murine cardiomyocytes. FEBS Lett 2005;579:5163‑9.
Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L,
Drevon CA, et al. Adiponectin and its receptors are expressed in
bone‑forming cells. Bone 2004;35:842‑9.
Crawford LJ, Peake R, Price S, Morris TC, Irvine AE.
Adiponectin is produced by lymphocytes and is a negative
regulator of granulopoiesis. J Leukoc Biol 2010;88:807‑11.
Paschke L, Zemleduch T, Rucinski M, Ziolkowska A, Szyszka M,
Malendowicz LK. Adiponectin and adiponectin receptor system
in the rat adrenal gland: Ontogenetic and physiologic regulation,
and its involvement in regulating adrenocortical growth and
steroidogenesis. Peptides 2010;31:1715‑24.
Caminos JE, Nogueiras R, Gallego R, Bravo S, Tovar S,
Garcia‑Caballero T, et al. Expression and regulation of
adiponectin and receptor in human and rat placenta. J Clin
Endocrinol Metab 2005;90:4276‑86.
Caminos JE, Nogueiras R, Gaytan F, Pineda R, Gonzalez CR,
Barreiro ML, et al. Novel expression and direct effects of
adiponectin in the rat testis. Endocrinology 2008;149:3390‑402.
Chabrolle C, Tosca L, Dupont J. Regulation of adiponectin and
its receptors in rat ovary by human chorionic gonadotrophin
treatment and potential involvement of adiponectin in granulosa
cell steroidogenesis. Reproduction 2007;133:719‑31.
Rodriguez‑Pacheco F, Martinez‑Fuentes AJ, Tovar S, Pinilla L,
Tena‑Sempere M, Dieguez C, et al. Regulation of pituitary cell
function by adiponectin. Endocrinology 2007;148:401‑10.
Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY. Expression of
adiponectin and its receptors in livers of morbidly obese patients
with non‑alcoholic fatty liver disease. J Gastroenterol Hepatol
;24:233‑7.
Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of
Acrp30/adiponectin structural and functional paralogs. Proc Natl
Acad Sci U S A 2004;101:10302‑7.
Fruebis J, Tsao TS, Javorschi S, Ebbets‑Reed D, Erickson MR,
Yen FT, et al. Proteolytic cleavage product of 30‑kDa adipocyte
complement‑related protein increases fatty acid oxidation in
muscle and causes weight loss in mice. Proc Natl Acad Sci U S
A 2001;98:2005‑10.
Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K,
Miyagawa J, et al. Paradoxical decrease of an adipose‑specific protein, adiponectin, in obesity. Biochem Biophys Res Commun
;257:79‑83.
Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O,
Ebinuma H, et al. Measurement of the high‑molecular weight
form of adiponectin in plasma is useful for the prediction of
insulin resistance and metabolic syndrome. Diabetes Care
;29:1357‑62.
Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y,
et al. Selective suppression of endothelial cell apoptosis by
the high molecular weight form of adiponectin. Circ Res
;94:e27‑31.
Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T,
Berger JP, et al. Complex distribution, not absolute amount
of adiponectin, correlates with thiazolidinedione‑mediated
improvement in insulin sensitivity. J Biol Chem
;279:12152‑62.
Wang Y, Lam KS, Yau MH, Xu A. Post‑translational
modifications of adiponectin: Mechanisms and functional
implications. Biochem J 2008;409:623‑33.
Andersen KK, Frystyk J, Wolthers OD, Heuck C, Flyvbjerg A.
Gender differences of oligomers and total adiponectin during
puberty: A cross‑sectional study of 859 Danish school children.
J Clin Endocrinol Metab 2007;92:1857‑62.
Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A,
Devlin AM. Total and high molecular weight adiponectin and
ethnic‑specific differences in adiposity and insulin resistance:
A cross‑sectional study. Cardiovasc Diabetol 2013;12:170.
Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK,
Boyko EJ, et al. Relationship of adiponectin to body fat
distribution, insulin sensitivity and plasma lipoproteins:
Evidence for independent roles of age and sex. Diabetologia
;46:459‑69.
Arai Y, Nakazawa S, Kojima T, Takayama M, Ebihara Y,
Shimizu KI, et al. High adiponectin concentration and its role
for longevity in female centenarians. Geriatr Gerontol Int
;6:32‑9.
Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL,
Mantzoros CS. Diurnal and ultradian dynamics of serum
adiponectin in healthy men: Comparison with leptin, circulating
soluble leptin receptor, and cortisol patterns. J Clin Endocrinol
Metab 2003;88:2838‑43.
Swarbrick MM, Havel PJ. Physiological, pharmacological, and
nutritional regulation of circulating adiponectin concentrations in
humans. Metab Syndr Relat Disord 2008;6:87‑102.
Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S,
et al. Cloning of adiponectin receptors that mediate antidiabetic
metabolic effects. Nature 2003;423:762‑9.
Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF.
T‑cadherin is a receptor for hexameric and high‑molecular‑weight
forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A
;101:10308‑13.
Yamauchi T, Iwabu M, Okada‑Iwabu M, Kadowaki T.
Adiponectin receptors: A review of their structure, function
and how they work. Best Pract Res Clin Endocrinol Metab
;28:15‑23.
Kharroubi I, Rasschaert J, Eizirik DL, Cnop M. Expression of
adiponectin receptors in pancreatic beta cells. Biochem Biophys
Res Commun 2003;312:1118‑22.
Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T,
Iwabu M, et al. Targeted disruption of AdipoR1 and AdipoR2
causes abrogation of adiponectin binding and metabolic actions.
Nat Med 2007;13:332‑9.
Bjursell M, Ahnmark A, Bohlooly YM, William‑Olsson L,
Rhedin M, Peng XR, et al. Opposing effects of adiponectin
receptors 1 and 2 on energy metabolism. Diabetes
;56:583‑93.
Matsuda K, Fujishima Y, Maeda N, Mori T, Hirata A,
Sekimoto R, et al. Positive feedback regulation between
adiponectin and T‑cadherin impacts adiponectin levels in tissue
and plasma of male mice. Endocrinology 2015;156:934‑46.
Fukuda S, Kita S, Obata Y, Fujishima Y, Nagao H, Masuda S,
et al. The unique prodomain of T‑cadherin plays a key role in
adiponectin binding with the essential extracellular cadherin
repeats 1 and 2. J Biol Chem 2017;292:7840‑9.
Obata Y, Kita S, Koyama Y, Fukuda S, Takeda H, Takahashi M,
et al. Adiponectin/T‑cadherin system enhances exosome
biogenesis and decreases cellular ceramides by exosomal release.
JCI Insight 2018;3:e99680.
Bauche IB, Ait El Mkadem S, Rezsohazy R, Funahashi T,
Maeda N, Miranda LM, et al. Adiponectin downregulates
its own production and the expression of its AdipoR2
receptor in transgenic mice. Biochem Biophys Res Commun
;345:1414‑24.
Kim MJ, Maachi M, Debard C, Loizon E, Clement K,
Bruckert E, et al. Increased adiponectin receptor‑1 expression in
adipose tissue of impaired glucose‑tolerant obese subjects during
weight loss. Eur J Endocrinol 2006;155:161‑5.
Bluher M. Adipose tissue inflammation: A cause or consequence
of obesity‑related insulin resistance? Clin Sci (Lond)
;130:1603‑14.
Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM,
Rasmussen M, Richelsen B. Adiponectin receptors in human
adipose tissue: Effects of obesity, weight loss, and fat depots.
Obesity (Silver Spring) 2006;14:28‑35.
McAinch AJ, Steinberg GR, Mollica J, O’Brien PE, Dixon JB,
Macaulay SL, et al. Differential regulation of adiponectin
receptor gene expression by adiponectin and leptin in myotubes
derived from obese and diabetic individuals. Obesity (Silver
Spring) 2006;14:1898‑904.
Storgaard H, Poulsen P, Ling C, Groop L, Vaag AA.
Relationships of plasma adiponectin level and adiponectin
receptors 1 and 2 gene expression to insulin sensitivity and
glucose and fat metabolism in monozygotic and dizygotic twins.
J Clin Endocrinol Metab 2007;92:2835‑9.
Ordelheide AM, Heni M, Gommer N, Gasse L, Haas C,
Guirguis A, et al. The myocyte expression of adiponectin
receptors and PPARδ is highly coordinated and reflects
lipid metabolism of the human donors. Exp Diabetes Res
;2011:692536.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H,
et al. Recent advances in the relationship between obesity,
inflammation, and insulin resistance. Eur Cytokine Netw
;17:4‑12.
Antuna‑Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: The
missing link between insulin resistance and obesity. Diabetes
Metab 2008;34:2‑11.
Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK,
Trumbauer ME, et al. Mice lacking adiponectin show decreased
hepatic insulin sensitivity and reduced responsiveness to
peroxisome proliferator‑activated receptor gamma agonists.
J Biol Chem 2006;281:2654‑60.
Semple RK, Cochran EK, Soos MA, Burling KA, Savage DB,
Gorden P, et al. Plasma adiponectin as a marker of insulin
receptor dysfunction: Clinical utility in severe insulin resistance.
Diabetes Care 2008;31:977‑9.
Okamoto M, Ohara‑Imaizumi M, Kubota N, Hashimoto S, Eto K, Kanno T, et al. Adiponectin induces insulin secretion
in vitro and in vivo at a low glucose concentration. Diabetologia
;51:827‑35.
Wijesekara N, Krishnamurthy M, Bhattacharjee A, Suhail A,
Sweeney G, Wheeler MB. Adiponectin‑induced ERK and Akt
phosphorylation protects against pancreatic beta cell apoptosis
and increases insulin gene expression and secretion. J Biol Chem
;285:33623‑31.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S,
et al. Adiponectin stimulates glucose utilization and fatty‑acid
oxidation by activating AMP‑activated protein kinase. Nat Med
;8:1288‑95.
Ceddia RB, Somwar R, Maida A, Fang X, Bikopoulos G,
Sweeney G. Globular adiponectin increases GLUT4 translocation
and glucose uptake but reduces glycogen synthesis in rat skeletal
muscle cells. Diabetologia 2005;48:132‑9.
Mao X, Kikani CK, Riojas RA, Langlais P, Wang L,
Ramos FJ, et al. APPL1 binds to adiponectin receptors and
mediates adiponectin signalling and function. Nat Cell Biol
;8:516‑23.
Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L.
Endogenous glucose production is inhibited by the
adipose‑derived protein Acrp30. J Clin Invest 2001;108:1875‑81.
Fu Y, Luo N, Klein RL, Garvey WT. Adiponectin promotes
adipocyte differentiation, insulin sensitivity, and lipid
accumulation. J Lipid Res 2005;46:1369‑79.
Lim S, Meigs JB. Ectopic fat and cardiometabolic and vascular
risk. Int J Cardiol 2013;169:166‑76.
Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI,
et al. Enhanced muscle fat oxidation and glucose transport by
ACRP30 globular domain: Acetyl‑CoA carboxylase inhibition
and AMP‑activated protein kinase activation. Proc Natl Acad Sci
U S A 2002;99:16309‑13.
Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB.
Adiponectin increases fatty acid oxidation in skeletal muscle
cells by sequential activation of AMP‑activated protein
kinase, p38 mitogen‑activated protein kinase, and peroxisome
proliferator‑activated receptor alpha. Diabetes 2006;55:2562‑70.
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K,
et al. The fat‑derived hormone adiponectin reverses insulin
resistance associated with both lipoatrophy and obesity. Nat Med
;7:941‑6.
Liu Q, Yuan B, Lo KA, Patterson HC, Sun Y, Lodish HF.
Adiponectin regulates expression of hepatic genes critical
for glucose and lipid metabolism. Proc Natl Acad Sci U S A
;109:14568‑73.
Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y,
Ohashi K, et al. Adiponectin specifically increased tissue
inhibitor of metalloproteinase‑1 through interleukin‑10
expression in human macrophages. Circulation 2004;109:2046‑9.
Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H,
et al. Adiponectin, an adipocyte‑derived plasma protein, inhibits
endothelial NF‑kappaB signaling through a cAMP‑dependent
pathway. Circulation 2000;102:1296‑301.
Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P,
Jimenez‑Chillaron JC. Sexual differentiation, pregnancy, calorie
restriction, and aging affect the adipocyte‑specific secretory
protein adiponectin. Diabetes 2003;52:268‑76.
Gui Y, Silha JV, Murphy LJ. Sexual dimorphism and regulation
of resistin, adiponectin, and leptin expression in the mouse. Obes
Res 2004;12:1481‑91.
Yu H, Chhabra KH, Thompson Z, Jones GL, Kiran S,
Shangguan G, et al. Hypothalamic POMC deficiency
increases circulating adiponectin despite obesity. Mol Metab
;35:100957.
Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H,
Nagaretani H, et al. Androgens decrease plasma adiponectin,
an insulin‑sensitizing adipocyte‑derived protein. Diabetes
;51:2734‑41.
Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M,
Matsui J, et al. Disruption of adiponectin causes insulin resistance
and neointimal formation. J Biol Chem 2002;277:25863‑6.
Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M,
Maeda N, et al. Role of adiponectin in preventing vascular
stenosis. The missing link of adipo‑vascular axis. J Biol Chem
;277:37487‑91.
Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M,
et al. Adiponectin reduces atherosclerosis in apolipoprotein
E‑deficient mice. Circulation 2002;106:2767‑70.
Kato H, Kashiwagi H, Shiraga M, Tadokoro S, Kamae T,
Ujiie H, et al. Adiponectin acts as an endogenous antithrombotic
factor. Arterioscler Thromb Vasc Biol 2006;26:224‑30.
Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S,
Ohashi K, et al. Adiponectin protects against myocardial
ischemia‑reperfusion injury through AMPK‑ and
COX‑2‑dependent mechanisms. Nat Med 2005;11:1096‑103.
Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al.
Genetic variation in the gene encoding adiponectin is associated
with an increased risk of type 2 diabetes in the Japanese
population. Diabetes 2002;51:536‑40.
Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM,
Ramachandran A. Plasma adiponectin is an independent
predictor of type 2 diabetes in Asian indians. Diabetes Care
;26:3226‑9.
Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T.
Adiponectin, an adipocyte‑derived protein, predicts future insulin
resistance: Two‑year follow‑up study in Japanese population.
J Clin Endocrinol Metab 2004;89:87‑90.
Zhou L, Liu M, Zhang J, Chen H, Dong LQ, Liu F. DsbA‑L
alleviates endoplasmic reticulum stress‑induced adiponectin
downregulation. Diabetes 2010;59:2809‑16.
Soares AF, Guichardant M, Cozzone D, Bernoud‑Hubac N,
Bouzaidi‑Tiali N, Lagarde M, et al. Effects of oxidative stress
on adiponectin secretion and lactate production in 3T3‑L1
adipocytes. Free Radic Biol Med 2005;38:882‑9.
Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y,
Tanaka S, Tataranni PA, et al. Adiponectin and development
of type 2 diabetes in the Pima Indian population. Lancet
;360:57‑8.
Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M,
Matsuda M, et al. Association of adiponectin mutation with
type 2 diabetes: A candidate gene for the insulin resistance
syndrome. Diabetes 2002;51:2325‑8.
Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M,
Boeing H, et al. Adiponectin and protection against type 2
diabetes mellitus. Lancet 2003;361:226‑8.
Vansaun MN. Molecular pathways: Adiponectin and leptin
signaling in cancer. Clin Cancer Res 2013;19:1926‑32.
Schott S, Schneeweiss A, Sohn C. Breast cancer and diabetes
mellitus. Exp Clin Endocrinol Diabetes 2010;118:673‑7.
Rzepka‑Gorska I, Bedner R, Cymbaluk‑Ploska A,
Chudecka‑Glaz A. Serum adiponectin in relation to endometrial
cancer and endometrial hyperplasia with atypia in obese women.
Eur J Gynaecol Oncol 2008;29:594‑7.
Jin JH, Kim HJ, Kim CY, Kim YH, Ju W, Kim SC.
Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer. Obstet
Gynecol Sci 2016;59:279‑85.
Tiwari A, Ocon‑Grove OM, Hadley JA, Giles JR, Johnson PA,
Ramachandran R. Expression of adiponectin and its receptors is
altered in epithelial ovarian tumors and ascites‑derived ovarian
cancer cell lines. Int J Gynecol Cancer 2015;25:399‑406.
Li X, Yu Z, Fang L, Liu F, Jiang K. Expression of adiponectin
receptor‑1 and prognosis of epithelial ovarian cancer patients.
Med Sci Monit 2017;23:1514‑21.
Hoffmann M, Gogola J, Ptak A. Adiponectin reverses the
proliferative effects of estradiol and IGF‑1 in human epithelial
ovarian cancer cells by downregulating the expression of their
receptors. Horm Cancer 2018;9:166‑74.
Mitsiades N, Pazaitou‑Panayiotou K, Aronis KN, Moon HS,
Chamberland JP, Liu X, et al. Circulating adiponectin is
inversely associated with risk of thyroid cancer: In vivo and
in vitro studies. J Clin Endocrinol Metab 2011;96:E2023‑8.
Hu MB, Xu H, Hu JM, Zhu WH, Yang T, Jiang HW, et al.
Genetic polymorphisms in leptin, adiponectin and their
receptors affect risk and aggressiveness of prostate cancer:
Evidence from a meta‑analysis and pooled‑review. Oncotarget
;7:81049‑61.
Michalakis K, Williams CJ, Mitsiades N, Blakeman J,
Balafouta‑Tselenis S, Giannopoulos A, et al. Serum adiponectin
concentrations and tissue expression of adiponectin receptors are
reduced in patients with prostate cancer: A case control study.
Cancer Epidemiol Biomarkers Prev 2007;16:308‑13.
Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA,
et al. Tumor expression of adiponectin receptor 2 and lethal
prostate cancer. Carcinogenesis 2015;36:639‑47.
Jiang J, Fan Y, Zhang W, Shen Y, Liu T, Yao M, et al.
Adiponectin suppresses human pancreatic cancer growth through
attenuating the beta‑catenin signaling pathway. Int J Biol Sci
;15:253‑64.
Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, et al.
Adiponectin represses colon cancer cell proliferation via
AdipoR1‑ and ‑R2‑mediated AMPK activation. Mol Endocrinol
;24:1441‑52.